Abstract Search

ea0063p946 | Diabetes, Obesity and Metabolism 3 | ECE2019

Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

Peris Begona Pla , Sanchez Clara Marijuan , Moreno Nerea Aguirre , Alday Inigo Hernando , Blanco Sara Jimenez , Nunez Miguel Sampedro , Moreno Rosa Giron , Azpiroz Monica Marazuela , Martin Alfonso Arranz

Introduction: Abnormal glucose metabolism (AGM) is the most common extra-pulmonary comorbidity in people with cystic fibrosis (CF) and has a high negative impact on the underlying disease. Elevated postprandial glucose level is usually the first manifestation, which is traditionally detected by 75-gram oral glucose tolerance test (OGTT). The aim of this study was to evaluate glycemic pattern during continuous glucose monitoring (CGM) in patients with impaired glucose metabolis...

1 shares

Endocrine Abstracts

Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

BiosciAbstracts